Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05517811 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT05517811 · ClinicalTrials.gov record · last posted 2026-08-24

Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection

Name: Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection — clinical trial record (NCT05517811)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TEG

StatusRecruiting

PhaseNot specified

SponsorUniversity of Colorado, Denver

Started2022-06-26

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The investigators hypothesize that abnormalities in thromboelastography (TEG) parameters in patients with liver, pancreas, biliary, esophageal, colorectal, and lung adenocarcinoma can serve as biomarkers for oncologic disease burden, cancer recurrence and overall survival as well as thrombotic and hemorrhagic post-operative complications. The investigators further hypothesize that there is histologic pathology correlates to pre-operative TEG abnormalities, and that it identifies patients with virulent tumor biology.

Protocol amendment history 1 change detected by DataLookout

2026-08-25

Enrollment reduced: 400 → 200 participants

Trial Details

NCT Number	NCT05517811
Lead Sponsor	University of Colorado, Denver Collaborators: Haemonetics Corporation
Conditions	Liver Cancer, Esophageal Cancer, Colorectal Cancer, Lung Adenocarcinoma, Control, Pancreas Cancer, Biliary Cancer
Enrollment	200 participants
Start Date	2022-06-26
Primary Completion	2028-05-31 (estimated)
Study Completion	2028-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-24